Account
Inquiry
Tirzepatide pens contain a novel dual GIP and GLP-1 receptor agonist peptide for research purposes. This pharmaceutical grade compound demonstrates significant potential in metabolic studies, particularly for glucose regulation and weight management research.
The tirzepatide pens are available in various concentrations ranging from 5mg to 45mg per vial, packaged in sets of 10 vials. Each batch undergoes rigorous HPLC testing to ensure 99% purity standards are met.
Research indicates tirzepatide's unique mechanism of action as both a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Clinical studies have shown promising results in glycemic control and substantial weight reduction in test subjects.
Our tirzepatide pens are strictly for research use only. The product should be stored at 2-8°C, protected from light, and has a shelf life of 24 months when properly stored.
